Based on forecasted data, the leukemia mortality rate for Canadian women is projected to decline gradually from 4.8 per 100,000 in 2024 and 2025 to 4.6 in 2028. This signifies a notable decreasing trend, with a year-on-year decline of approximately 2.1% by 2028 compared to 2026 and a CAGR of around -1.1% over the five-year span. In 2023, the rate stood at 4.9.
Future trends to watch for include advancements in medical treatments and early detection methods, which could further decrease mortality rates. Monitoring healthcare policy changes and research investments will also be crucial in understanding potential shifts in these figures.
